GRI Bio, Inc. (GRI)
NASDAQ: GRI · Real-Time Price · USD
2.060
-0.140 (-6.36%)
At close: May 22, 2026, 4:00 PM EDT
2.050
-0.010 (-0.49%)
After-hours: May 22, 2026, 7:51 PM EDT
GRI Bio Market Cap
GRI Bio has a market cap or net worth of $2.98 million as of May 22, 2026. Its market cap has decreased by -2.81% in one year.
Market Cap
2.98M
Enterprise Value
-8.01M
1-Year Change
-2.81%
Ranking
Category
Stock Price
$2.06
Market Cap Chart
Since April 24, 2023, GRI Bio's market cap has decreased from $25.29M to $2.98M, a decrease of -88.23%. That is a compound annual growth rate of -50.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 22, 2026 | 2.98M | 19.17% |
| Dec 31, 2025 | 2.50M | -66.25% |
| Dec 31, 2024 | 7.40M | 326.73% |
| Dec 29, 2023 | 1.73M | -93.14% |
| Apr 24, 2023 | 25.29M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Decoy Therapeutics | 3.88M |
| Galmed Pharmaceuticals | 3.82M |
| AIM ImmunoTech | 3.73M |
| Azitra | 3.30M |
| Adial Pharmaceuticals | 2.97M |
| Ensysce Biosciences | 2.96M |
| Calidi Biotherapeutics | 2.70M |
| Valion Bio | 2.68M |